🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective single-center clinical study, which aims to obs...
Status
Recruiting
Location
Beijing Sanbo Brain Hospital
Start Date
2020-10-28
Trial ID
NCT04501718
Treatments Being Tested
The purpose of this study is to elucidate whether SentoClone® gives improve...
Status
Unknown
Location
Lunds Universitetssjukhus
Start Date
2009-10
Trial ID
NCT00991250
Treatments Being Tested
This research study is studying if the investigational drug, Pembrolizumab,...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2024-10-18
Trial ID
NCT06475235
Treatments Being Tested
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM A...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-07-30
Trial ID
NCT03970447
This clinical trial evaluates adding ferumoxytol and pharamcologic ascorbat...
Status
Active Not Recruiting
Location
Department of Radiation Oncology at University of Iowa
Start Date
2023-02-28
Trial ID
NCT04900792
Treatments Being Tested
The main purpose of this study is to explore the feasibility of selecting t...
Status
Recruiting
Location
Tianjin Medical Unversity Second Hospital
Start Date
2024-11-01
Trial ID
NCT06739395
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
Glioblastoma (GBM) is the primary intracranial malignant tumor with the hig...
Status
Recruiting
Location
Tianjin Medical University General Hospital
Start Date
2024-04-01
Trial ID
NCT06327451
Treatments Being Tested
The purpose of this study is to test the the efficacy and safety of Anlotin...
Status
Completed
Location
Zhejiang cancer hospital
Start Date
2019-03-19
Trial ID
NCT04119674
A Phase 2 study investigating the addition of cRIT 131I-omburtamab to irino...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2022-04-04
Trial ID
NCT04743661